Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder - Scorecard - MDSpire

Maternal Thyroid Hormone Imbalance and Risk of Autism Spectrum Disorder

  • By

  • Leena Elbedour

  • May Weinberg

  • Gal Meiri

  • Analya Michaelovski

  • Idan Menashe

  • November 25, 2025

  • 0 min

Share

Clinical Scorecard: The Link Between Maternal Thyroid Hormone Dysregulation and Autism Spectrum Disorder Risk

At a Glance

CategoryDetail
ConditionMaternal thyroid hormone dysregulation during pregnancy and offspring autism spectrum disorder (ASD)
Key MechanismsMaternal thyroid hormones are essential for fetal neurodevelopment; disruptions in maternal thyroid hormone levels, especially hypothyroidism across pregnancy trimesters, may increase ASD risk in offspring
Target PopulationPregnant women with thyroid dysfunction and their offspring
Care SettingObstetric and prenatal care in tertiary hospital and health maintenance organization settings

Key Highlights

  • Persistent maternal hypothyroidism across multiple trimesters is associated with increased ASD risk in offspring in a dose-response manner.
  • Adequately treated chronic hypothyroidism alone is not significantly associated with increased ASD risk.
  • Routine thyroid function screening and timely treatment throughout pregnancy are important to mitigate ASD risk.

Guideline-Based Recommendations

Diagnosis

  • Screen maternal thyroid function routinely during pregnancy, including assessment across all trimesters.

Management

  • Provide timely and adequate treatment for maternal hypothyroidism to maintain euthyroid status throughout pregnancy.

Monitoring & Follow-up

  • Monitor thyroid hormone levels longitudinally during pregnancy to detect persistent hypothyroidism.

Risks

  • Persistent hypothyroidism during pregnancy increases offspring ASD risk; untreated or prolonged thyroid hormone imbalance poses neurodevelopmental risks.

Patient & Prescribing Data

Pregnant women diagnosed with hypothyroidism

Adequate treatment of chronic hypothyroidism reduces ASD risk, while untreated or persistent hypothyroidism across trimesters elevates risk.

Clinical Best Practices

  • Implement trimester-specific thyroid function testing to identify duration and persistence of hypothyroidism.
  • Initiate and adjust thyroid hormone replacement therapy promptly to maintain normal hormone levels.
  • Consider ethnic and regional population characteristics when evaluating thyroid dysfunction and ASD risk.
  • Educate patients on the importance of thyroid health during pregnancy for fetal neurodevelopment.

References

Original Source(s)

Related Content